Suicide re-attempt risk considerably decreased after an unique psychiatric intervention

The trial, conducted by Konrad Michel and associates at the University Health center of Psychiatry, Bern, Switzerland, is the first randomized research of the Attempted Suicide Short Intervention Program (ASSIP), a collaborative patient-therapist intervention for …See all stories on this topic

New CEO for Charlotte mental-health campus

Kuroski-Mazzei is board accredited in psychiatry, forensic psychiatry and addiction medication. She currently works as the medical director of the San Diego Expert Group for American Addiction Centers’ Southern California operations. “I am …See all stories on this topic

Licensing contract will advance unique neuropeptide treatment for anxiety

The Centre for Addiction and Mental Health and Impel NueroPharma recently signed a licensing arrangement to advance a neuropeptide-based treatment for anxiety. The arrangement follows findings that suggested the therapy, which enhances coupling of the D1 and …See all stories on this topic

PAPHR psychiatry wait times a ‘issue’

Psychiatry wait times are a “issue” according to statistics presented at a Prince Albert Parkland Health Region board meeting last week. Psychiatry clients are categorized as very serious, serious, moderate or moderate. Each classification has a goal of when …See all stories on this topic

Minutes of Severe Tension Can Trigger Molecular Alterations in Immune Reaction

“In our everyday lives, acute stress is workable and does not cause physiological damage,” stated study co-author Brinda Rana, PhD, associate teacher in the Department of Psychiatry at UC San Diego School of Medicine. “Nevertheless, for those who …See all stories on this subject